LumiraDx LMDX Stock
LumiraDx Price Chart
LumiraDx LMDX Financial and Trading Overview
| LumiraDx stock price | 0.02 USD |
| Previous Close | 0.38 USD |
| Open | 0.37 USD |
| Bid | 0 USD x 4000 |
| Ask | 0 USD x 1300 |
| Day's Range | 0.37 - 0.42 USD |
| 52 Week Range | 0.33 - 3.46 USD |
| Volume | 141.53K USD |
| Avg. Volume | 182.33K USD |
| Market Cap | 233.93M USD |
| Beta (5Y Monthly) | 0.955481 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.39 USD |
LMDX Valuation Measures
| Enterprise Value | 456.11M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.0885293 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.5570829 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 3.036 |
| Enterprise Value/EBITDA | -2.163 |
Trading Information
LumiraDx Stock Price History
| Beta (5Y Monthly) | 0.955481 |
| 52-Week Change | -88.10% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.46 USD |
| 52 Week Low | 0.33 USD |
| 50-Day Moving Average | 0.54 USD |
| 200-Day Moving Average | 0.92 USD |
LMDX Share Statistics
| Avg. Volume (3 month) | 182.33K USD |
| Avg. Daily Volume (10-Days) | 120K USD |
| Shares Outstanding | 164.32M |
| Float | 69.96M |
| Short Ratio | 4.5 |
| % Held by Insiders | 79.53% |
| % Held by Institutions | 26.58% |
| Shares Short | 512.78K |
| Short % of Float | 0.80% |
| Short % of Shares Outstanding | 0.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -290.38% |
| Operating Margin (ttm) | -157.97% |
| Gross Margin | 6.76% |
| EBITDA Margin | -140.37% |
Management Effectiveness
| Return on Assets (ttm) | -28.21% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 150.24M USD |
| Revenue Per Share (ttm) | 0.5 USD |
| Quarterly Revenue Growth (yoy) | -82.50% |
| Gross Profit (ttm) | 61.02M USD |
| EBITDA | -210888992 USD |
| Net Income Avi to Common (ttm) | -436256000 USD |
| Diluted EPS (ttm) | -1.47 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 68.05M USD |
| Total Cash Per Share (mrq) | 0.21 USD |
| Total Debt (mrq) | 400.06M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.538 |
| Book Value Per Share (mrq) | -0.481 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -185220000 USD |
| Levered Free Cash Flow (ttm) | -75049376 USD |
Profile of LumiraDx
| Country | United States |
| State | N/A |
| City | London |
| Address | 3 More London Riverside |
| ZIP | SE1 2AQ |
| Phone | 44 11 7284 2535 |
| Website | https://www.lumiradx.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 1210 |
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company is headquartered in London, the United Kingdom.
Q&A For LumiraDx Stock
What is a current LMDX stock price?
LumiraDx LMDX stock price today per share is 0.02 USD.
How to purchase LumiraDx stock?
You can buy LMDX shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for LumiraDx?
The stock symbol or ticker of LumiraDx is LMDX.
Which industry does the LumiraDx company belong to?
The LumiraDx industry is Diagnostics & Research.
How many shares does LumiraDx have in circulation?
The max supply of LumiraDx shares is 0.
What is LumiraDx Price to Earnings Ratio (PE Ratio)?
LumiraDx PE Ratio is now.
What was LumiraDx earnings per share over the trailing 12 months (TTM)?
LumiraDx EPS is 0 USD over the trailing 12 months.
Which sector does the LumiraDx company belong to?
The LumiraDx sector is Healthcare.
LumiraDx LMDX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17601.05 USD — |
+0.87
|
8.38B USD — | 17181.27 USD — | 17716.52 USD — | — - | 8.38B USD — |
| NASDAQ Global Market Composite NQGM | 1848.67 USD — |
+1.89
|
— — | 1786.7 USD — | 1857.32 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 942.47 USD — |
+1.43
|
— — | 920.56 USD — | 943.62 USD — | — - | — — |
- {{ link.label }} {{link}}